Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Research Article

Outcomes of Clinical Treatments Among Patients with Diabetes Mellitus in Selangor, Malaysia: A Retrospective Study

Author(s): Zamalia Mahmud*, Syahidatul Alyia Abrahhim and Saperi Sulong

Volume 17, Issue 7, 2021

Published on: 12 January, 2021

Article ID: e011221190236 Pages: 7

DOI: 10.2174/1573399817999210112191330

Abstract

Background: It is important to assess how well patients respond to their medical treatments by observing the results that appear during the clinical treatments. As such, the clinical treatments and results must obtain information on how effective recommended treatments were for patients with diabetes.

Objective: This study examines how patients with diabetes mellitus responded towards their clinical treatments, where the probability distribution of patients and the types of treatment received were derived from the Rasch probabilistic model.

Methods: This is a retrospective study wherein data were collected from patients’ medical records at a local public hospital in Selangor, Malaysia. Clinical and demographic information such as fasting blood glucose, hemoglobin A1c (HbA1c), family history, type of diabetes (type 1 or type 2), types of medication (oral or insulin), compliance with treatments, gender, race and age were chosen as the agents of measurement.

Results: The use of Rasch analysis in the present study helped to compare the patients’ responses towards the DM treatments and identify the types of treatment they received. Results from the Wright map show that a majority of the diabetes mellitus patients who were diagnosed with type 2 diabetes have no controlled readings of HbA1c during their first and second visits to the medical center. However, patients with a family history of diabetes mellitus who took oral medication have controlled readings of fasting blood glucose based on the probabilistic outcomes of the treatment received by the patients.

Conclusion: Controlled readings were found only in the readings of fasting blood glucose during the first and second visits, followed by family history, types of medication received, and compliance with the treatment. This study has recommended that type 2 patients with diabetes without a family history of diabetes mellitus need to exercise more control over the readings of HbA1c.

Keywords: Diabetes mellitus, clinical treatments, outcomes, rasch measurement model, fasting blood glucose, HbA1c.

[1]
Hussein Z, Taher SW, Gilcharan Singh HK, Chee Siew Swee W. Diabetes care in Malaysia: Problems, new models, and solutions. Ann Glob Health 2015; 81(6): 851-62.
[http://dx.doi.org/10.1016/j.aogh.2015.12.016] [PMID: 27108152]
[2]
Malla S, Hobbs JE, Perger O. Valuing the health benefits of a novel functional food. Can J Agric Econ 2007; 55(1): 115-36.
[http://dx.doi.org/10.1111/j.1744-7976.2007.00083.x]
[3]
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5): 1047-53.
[http://dx.doi.org/10.2337/diacare.27.5.1047] [PMID: 15111519]
[4]
World Health Organization. Fact sheet: Diabetes. https://www.who.int/news-room/fact-sheets/detail/diabetes
[5]
Institute of Public Health. National health and morbidity survey: Non-communicable diseases, risk factors and other health problem. Putrajaya, Malaysia: Ministry of Health, 2010.
[6]
Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992; 340(8825): 925-9.
[http://dx.doi.org/10.1016/0140-6736(92)92814-V] [PMID: 1357346]
[7]
Jiang YD, Chuang LM, Wu HP, et al. Assessment of the function and effect of diabetes education programs in Taiwan. Diabetes Res Clin Pract 1999; 46(2): 177-82.
[http://dx.doi.org/10.1016/S0168-8227(99)00085-6] [PMID: 10724098]
[8]
Festa A, D’Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102(1): 42-7.
[http://dx.doi.org/10.1161/01.CIR.102.1.42] [PMID: 10880413]
[9]
Omar ZA, Idris R, Jadin I. Community-based programs in diabetes control. NCD Malaysia 2002; 1: 12-5.
[10]
The Star Online. Malaysia has highest rate of diabetes in Asia, says Nadi chairman. 2018. https://www.thestar.com.my/news/nation/2018/07/25/malaysia-has-highest-rate-of-diabetes-in-asia-says-nadi-chairman
[11]
Çaliskan D, Ozdemir O, Ocaktan E, Idil A. Evaluation of awareness of diabetes mellitus and associated factors in four health center areas. Patient Educ Couns 2006; 62(1): 142-7.
[http://dx.doi.org/10.1016/j.pec.2005.06.018] [PMID: 16139985]
[12]
Snoek FJ. Breaking the barriers to optimal glycaemic control--what physicians need to know from patients’ perspectives. Int J Clin Pract Suppl 2002; 129(129): 80-4.
[PMID: 12166612]
[13]
Grill V, Persson G, Carlsson S, et al. Family history of diabetes in middle-aged Swedish men is a gender unrelated factor which associates with insulinopenia in newly diagnosed diabetic subjects. Diabetologia 1999; 42(1): 15-23.
[http://dx.doi.org/10.1007/s001250051106] [PMID: 10027572]
[14]
Valdez R. Detecting undiagnosed type 2 diabetes: family history as a risk factor and screening tool. J Diabetes Sci Technol 2009; 3(4): 722-6.
[http://dx.doi.org/10.1177/193229680900300417] [PMID: 20144319]
[15]
Padaki S, Vijayakrishna K, Dambal A, et al. Anthropometry and physical fitness in individuals with family history of type-2 diabetes mellitus: A comparative study. Indian J Endocrinol Metab 2011; 15(4): 327-30.
[http://dx.doi.org/10.4103/2230-8210.85595] [PMID: 22029005]
[16]
Nayak BS, Sobrian A, Latiff K, et al. The association of age, gender, ethnicity, family history, obesity and hypertension with type 2 diabetes mellitus in Trinidad. Diabetes Metab Syndr 2014; 8(2): 91-5.
[http://dx.doi.org/10.1016/j.dsx.2014.04.018] [PMID: 24907173]
[17]
Linacre JM. A user’s guide to WINSTEPS.
[18]
Bond TG, Fox CM. Applying the Rasch model: Fundamental measurement in the human science. (2nd ed.), New Jersey, NJ: Lawrence Erlbaum Associates 2007
[19]
Echtay A, Tsur A, Hasan MI, et al. Clinical experience with insulin detemir in patients with type 2 diabetes from the near East countries. Diabetes Ther 2013; 4(2): 399-408.
[http://dx.doi.org/10.1007/s13300-013-0041-z] [PMID: 24108581]
[20]
Mathieu C, Barnett AH, Brath H, et al. Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE). Int J Clin Pract 2013; 67(10): 947-56.
[http://dx.doi.org/10.1111/ijcp.12252] [PMID: 23961850]
[21]
Oguz A, Benroubi M, Brismar K, et al. Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study. Curr Med Res Opin 2013; 29(8): 911-20.
[http://dx.doi.org/10.1185/03007995.2013.803053] [PMID: 23659564]
[22]
Rosales R, Abou Jaoude E, Al-Arouj M, et al. Clinical effectiveness and safety of vildagliptin in >19 000 patients with type 2 diabetes: the GUARD study. Diabetes Obes Metab 2015; 17(6): 603-7.
[http://dx.doi.org/10.1111/dom.12436] [PMID: 25586779]
[23]
Ji L, Bonnet F, Charbonnel B, et al. Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program. J Diabetes Complications 2017; 31(7): 1188-96.
[http://dx.doi.org/10.1016/j.jdiacomp.2017.03.011] [PMID: 28499961]
[24]
Yilmaz UD, Tarhan S. Determination of attitude and knowledge of type 2 diabetic patients towards insulin therapy in Northern Cyprus. J Pak Med Assoc 2017; 67(3): 343-9.
[PMID: 28303979]
[25]
Nural N, Hindistan S, Gürsoy AA, Bayrak N. Epidemiologic features and prognosis of patients who was diagnosed having type 2 diabetes mellitus and applied to a Community Health Center. Turk Silahli Kuvvetleri Koruyucu Hekim Bul 2009; 8(4): 297-306.
[26]
Kara K, Cinar S. The relation between diabetes care profile and metabolic control variables. Kafkas J Med Sci 2011; 1(2): 57-63.
[http://dx.doi.org/10.5505/kjms.2011.41736]
[27]
Zahari AZ, Yunivita V, Martha JW. Knowledge, attitude and practice of diabetes mellitus type 2 patients towards compliance to treatment in pusat kesehatan masyarakat. Althea Med J 2016; 3(3): 416-20.
[http://dx.doi.org/10.15850/amj.v3n3.871]

Rights & Permissions Print Cite
Article Metrics
15
1
© 2024 Bentham Science Publishers | Privacy Policy